Abstract
In this study, the diagnostic value of Schistosoma japonicum cathepsin B (SjCatB) was evaluated as an antigen for the early detection of S. japonicum infection. SjCatB is a key protease used by the cercaria to penetrate the intact skin of the host for transdermal infection. The early exposure of the host’s immune system to this enzyme may elicit early production of antibodies against this molecule. Therefore, the recombinant SjCatB (rSjCatB) was expressed in Escherichia coli with N-terminal 6xHis-tag. rSjCatB was tested for its performance as a diagnostic antigen using indirect enzyme-linked immunosorbent assay (ELISA) with sera from experimentally infected mice collected at > 8 weeks post-infection. Showing 100% sensitivity and 95.0% specificity in the ELISA, rSjCatB was then evaluated with sera from experimentally infected mice collected at 1–7 weeks post-infection to determine how early the antibodies can be detected. Results showed that as early as 6 weeks post-infection, 2 of the 3 infected mice were found to be positive with the antibodies against SjCatB. Furthermore, the potential of the recombinant antigen in detecting human schistosomiasis was evaluated with archived serum samples collected from individuals who had been diagnosed with S. japonicum infection by stool examination. Results showed 86.7% sensitivity and 96.7% specificity suggesting its high diagnostic potential for human schistosomiasis. In addition, SjCatB showed minimal cross-reaction with the sera collected from patients with other parasitic diseases. In conclusion, the results of this study suggest that SjCatB will be useful in the development of a sensitive and specific early detection test for S. japonicum infection.
Similar content being viewed by others
Introduction
Schistosomiasis is one of the neglected tropical diseases (NTDs) that causes chronic debilitating illness in infected individuals affecting millions of people globally (Chitsulo et al. 2000). In tropical countries, the socioeconomic and public health impact of the disease is second only to malaria (CDC 2017). Schistosoma japonicum, the most prevalent species in Asia, is found in China, the Philippines, and some parts of Indonesia (Chitsulo et al. 2000). Due to the huge number of eggs excreted by the female worm, S. japonicum is considered to be the most pathogenic among the schistosomes that are infective to humans (Mahmoud 2001). Recent reports of emergence of new endemic foci being provable to be attributed to the migration of infected individuals or animals indicate that new cases of human schistosomiasis pose a threat to the elimination of the disease (Leonardo et al. 2015; Patz et al. 2000). The lack of effective screening method for humans and animals from endemic areas could lead to the introduction of the disease in non-endemic areas with environmental and ecological conditions that will satisfy the life cycle of the parasite.
A good diagnostic test that can be employed in the surveillance of schistosomiasis is that it is capable of detecting early cases of the disease. The early diagnosis of infection may prove useful especially in travelers potentially exposed to S. japonicum infection, where prompt treatment will definitely result in a positive outcome by killing the worms prior to egg deposition in vital organs and tissues (Karcher et al. 2008). Pathologic lesions associated with S. japonicum infection that mainly occur due to the deposition of eggs in various vital organs (Mahmoud 2001) may be avoided.
Being the first stage of the schistosome parasite to be exposed to the host’s immune system, the cercaria seems to be useful in providing the candidate antigens that might have the potentials for the early diagnosis of the disease. Certain antibodies against the antigens related to the cercaria have been detected early in the course of infection (Zhou et al. 2010). Soluble cercarial antigen (SCA) was previously reported to be a good early diagnostic antigen (Zhang et al. 2015). However, due to the nature of SCA being a crude antigen, there are difficulties associated with its mass production for field application, and cross-reaction with other parasitic infections has been observed (Zhou et al. 2010). S. japonicum cathepsin B (SjCatB) is a protease expressed throughout all life stages of the parasite. The highest level of expression was observed in the infective cercaria stage in which it is utilized by the parasite to penetrate the intact skin of the host. This important role of SjCatB in the parasite has made it an ideal target for vaccine and drug development (Liu et al. 2014; Curwen and Wilson 2003; Dvorak et al. 2008). Although S. mansoni cathepsin B has been evaluated for the serological diagnosis of S. japonicum and S. mansoni infection (Ruppel et al. 1987; González et al. 2015), the use of SjCatB as an authentic antigen for S. japonicum may provide a more sensitive and specific diagnostic target.
In the present study, recombinant SjCatB (rSjCatB) was produced and evaluated as a diagnostic antigen using indirect enzyme-linked immunosorbent assay (ELISA).
Materials and methods
Ethics statement
The collection of serum samples from patients in Sorsogon, the Philippines, were carried out in compliance with the ethical clearance sought from the University of the Philippines, Manila (clearance no: UPM REB 2011-098), which includes informed consent from the individuals involved in the study. The animal experiments were performed under the guidelines for animal experimentation of Obihiro University of Agriculture and Veterinary Medicine (permission number: 29-52).
Mice and rabbit serum samples
A total of 5 female, 8-week-old ICR mice (Clea Inc., Tokyo, Japan) were used to observe the antibody response against SjCatB in the course of the infection. Three of the 5 mice were percutaneously infected with 30 cercariae using S. japonicum Yamanashi strain obtained from the Department of Tropical Medicine and Parasitology, Dokkyo Medical University, Japan. Serum samples were collected from the experimental infection (n = 3) at 1-week interval for 7 weeks after the cercarial challenge. The animals were sedated using isoflurane, and blood was drawn from the dorsal tail vein using a G26 butterfly needle attached to a microhematocrit tube. The same sampling time was observed for the serum collection in 2 uninfected mice serving as negative controls. To determine the diagnostic value of SjCatB in experimental infection, a total of 40 mice were used. Twenty mice (n = 20) out of the 40 were infected with the parasite by percutaneous challenge with 30 cercariae, and serum samples from these mice were collected at > 8 weeks post-infection. Negative controls used were serum samples collected from uninfected mice (n = 20). Rabbit serum samples used for western blotting were derived from 2 Japanese white rabbit Icl strain (Ichikawa-ya, Chiba, Japan). One of the rabbits was infected with 2000 cercariae by a percutaneous route which was used as the positive control, while the other non-infected rabbit was used as the negative control. The serum samples from both rabbits were collected 11 weeks post-infection. Additionally, a mouse infected with 30 cercariae served as positive control, while the serum from the other non-infected mouse was used as a negative control. Serum samples were collected at 8 weeks post-infection. Upon termination of the experiment, all mice were humanely sacrificed by cervical dislocation following isoflurane administration and the rabbits were sacrificed following the overdosage of sodium pentobarbital administered intravenously.
Human serum samples
Archived serum samples from patients (n = 30) who had been confirmed by stool microscopy and a stool PCR for S. japonicum infection (Angeles et al. 2012) were used in this experiment. These samples were collected from Sorsogon, Philippines. Likewise, archived serum samples were used as negative controls. These were collected from US volunteers (n = 30) who had not previously visited S. japonicum endemic areas. To check the cross-reactivity of the antigen with other parasitic infections, archived serum samples from humans infected with Trichuris trichiura (n = 1), Paragonimus westermani (n = 11), Opisthorchis viverrini (n = 8), and Entamoeba histolytica (n = 10) were used.
Recombinant protein preparation
The complete coding sequence of SjCatB was retrieved from the S. japonicum genome database with the accession number X70968.1. Total RNA was extracted from 50 mg of the frozen adult worm by homogenizing it in 1 ml of TRIzol® reagent (Life Technologies, Inc., Frederic, MD, U.S.A.). cDNA was synthesized using PrimeScript™ (Takara Bio. Inc., Shiga, Japan). The double-stranded full-length coding sequence was amplified by a PCR with the following primers: 5′-GC GGA TCC ATG TTG AAA ATC GCA GTT-3′ (underline indicates the Bam HI site) and 5′-GC CTC GAG TTA GGT TTT TAT AAG TCC AG-3′ (underline indicates the Xho I site). The PCR product was cloned into the pCR 2.1-TOPO vector (Invitrogen, Carlsbad, CA, USA). The identity of the cloned sequence with the sequence deposited in the database was confirmed by sequencing using an ABI Prism 3100 Genetic Analyzer (Applied Biosystems, Carlsbad, CA, USA). The coding sequence was then double-digested with Bam HI and Xho I and was subcloned into pET-28a (+) vector (Novagen, Madison, WI, USA). The recombinant protein with 6xHis-tag on the N terminal was expressed using Escherichia coli (BL21) cells (Takara Bio) grown in Luria Bertani broth (Sigma-Aldrich, St. Louis, MO, USA) with kanamycin (50 μg/ml). The rSjCatB was purified with affinity chromatography using an Ni-NTA protein purification kit (Qiagen, Hilden, Germany) under denaturing conditions, and then the protein was dialyzed against cold phosphate-buffered saline (PBS) (pH 7.4) prior to use. The recombinant protein was quantified using a Pierce™ BCA protein assay kit (Thermo Fisher Scientific, Rockford, IL, USA), and its purity was confirmed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).
Western blotting
Two hundred nanograms of rSjCatB was resolved by 12% SDS-PAGE under non-reducing conditions. Sample buffer and the polypeptides were transferred onto a polyvinylidene difluoride (PVDF) membrane. The membrane strips were blocked with 5% skim milk in PBS overnight at 4 °C with constant shaking. Excess blocking buffer was removed by washing twice with PBS containing 0.05% Tween 20 (PBS-T). The strips were incubated with antibody or serum samples in separate reaction chambers for 1 h at room temperature with constant shaking. The monoclonal antibody (mAb) against 6xHis-tag (Thermo Fisher Scientific) was diluted 500 times using 1% bovine serum albumin with PBS-T (1%-BSA-PBS-T), while the mouse and rabbit sera were diluted 400 times with PBS-T. Human serum was diluted 200 times with 1%-BSA-PBS-T. After the incubation, the strips were washed three times with PBS-T and incubated with secondary antibody for either 1 h against mouse IgG, rabbit IgG, or human IgG conjugated with horseradish peroxidase (HRP) (GE Healthcare, Buckinghamshire, UK). The antigen-antibody reaction was visualized by chemiluminescence using SuperSignal™ (Thermo Fisher Scientific) and a chemiluminescent detection machine ImageQuant LAS 500 (GE Electric, Tokyo, Japan). Similarly, in order to determine the antigenicity of rSjCatB, 200 ng of cercarial lysate was resolved by SDS-PAGE and the polypeptides were transferred onto a PVDF membrane. The polypeptides were then probed by antibodies collected from a mouse immunized with rSjCatB.
ELISA
Each well of a 96-well polystyrene plate (Thermo Fisher Scientific) was coated with 200 ng of rSjCatB in 100 μl of carbonate/bicarbonate buffer (pH 9.6) overnight at 4 °C. The wells were washed three times with PBS to remove unbound antigens. The wells were blocked with 1%-BSA-PBS-T for 5 min. The mouse sera were diluted 200 times, while the human sera were diluted 400 times in 1%-BSA-PBS-T. For each sample, 100 μl of the diluted serum sample was delivered to each well in triplicate. The wells were incubated for 1 h at 37 °C and were subsequently washed three times using PBS. One hundred microliters of the secondary antibody, either HRP-conjugated anti-mouse IgG (diluted at 1:10,000) or HRP-conjugated anti-human IgG (diluted at 1:20,000), was added to each well. The wells were incubated for 1 h at 37 °C and were subsequently washed three times with PBS. The antigen-antibody reaction was detected by adding 100 μl of HRP substrate, tetramethylbenzidine (TMB) (KPL Inc., Gaithersburg, MD, USA), to the wells, and the enzymatic reaction was allowed to proceed for 10 min. The reaction was stopped by adding 50 μl of 1 M phosphoric acid, and the absorbance at 450 nm was measured using a microplate reader (Corona Electric, Ibaraki, Japan).
Statistical analysis
The sensitivity and specificity were analyzed using the MedCalc software program (version 16.4.3, MedCalc Software, Ostend, Belgium; https://www.medcalc.org; 2016).
Results
Purification and antigenicity of rSjCatB
The complete coding sequence of SjCatB was amplified by a PCR from cDNA synthesized from adult worm RNA and was cloned into the pCR plasmid vector for sequencing. The coding sequence was 1045 bp in size (Fig. 1a, b). The identity with the GenBank deposited sequence (X70968.1) was confirmed (data not shown). The coding sequence was then subcloned into pET 28a (+) plasmid vector for the recombinant protein expression in E. coli with isopropyl-thio-β-D-galactoside (IPTG) induction. The Ni-NTA column–purified rSjCatB was recognized as the strongest band seen in SDS-PAGE with a molecular mass of ~ 39 kDa, which was in good accordance with the size predicted from the SjCatB amino acid sequence (Fig. 1c).
Serological evaluation of recombinant antigen
The diagnostic potential of rSjCatB was evaluated in an ELISA with sera collected from experimentally infected mice. Twenty negative serum samples from normal uninfected mice were used to determine the cutoff value mean as the optical density (OD) value plus 2-fold standard deviation (SD), and the value was determined to be 0.075. Using this cutoff value, all 20 experimentally infected mice were determined to be positive (sensitivity = 100%), while 19 of the 20 normal uninfected mice were determined to be negative (specificity = 95.0%) (Fig. 2a).
The sera collected from experimentally infected mice at 0, 1, 2, 3, 4, 5, 6, and 7 weeks post-infection were evaluated for the antibody response against rSjCatB in ELISA. From as early as 6 weeks post-infection, sera from 2 of the 3 experimentally infected mice showed OD values higher than the cutoff value of 0.091. Sera from normal uninfected mice did not show OD values higher than the cutoff value (Fig. 2b).
The diagnostic potential of rSjCatB in an ELISA with sera from human clinical cases was also evaluated. Thirty serum samples from normal healthy US volunteers were used to determine the cutoff value (OD + 2SD), which was calculated to be 0.33. Using this cutoff value, 26 of 30 stool-confirmed clinical cases were determined to be positive (sensitivity = 86.7%), while 29 of 30 US volunteers were determined to be negative (specificity = 96.7%) (Fig. 2c).
A T. trichiura-positive sample showed no cross-reaction with the recombinant antigen. In contrast, 1 of the 11 P. westermani-positive samples, 3 of the 8 O. viverrini-positive samples, and 1 of the 10 E. histolytica-positive samples showed OD values that were slightly higher than the cutoff value (Fig. 2c). Statistical analysis revealed that there is a significant difference with the antibodies detected from uninfected individuals as compared with those infected with other parasites (data not shown).
Furthermore, rSjCatB was recognized in western blotting as a 39 kDa polypeptide with anti-6xHis-tag mAb as well as serum samples collected from experimentally infected animals and the stool-positive patients but not with normal serum samples (Fig. 1d). The antibodies raised against rSjCatB were able to recognize the enzyme as a 39 kDa polypeptide with western blotting in S. japonicum cercaria lysate (Fig.1f) which had been separated with SDS-PAGE (Fig. 1e). The results suggested that the recombinant protein was antigenically similar to the native protein.
Discussion
The current, most used diagnostic test for S. japonicum infection is stool microscopy, which is highly specific and easy to perform (Katz et al. 1972). However, the test has a disadvantage in detecting early infection and infection with low parasite burden (Pontes et al. 2003; Yu et al. 2007; Zhu 2005). In order to increase the sensitivity of the test, several modifications including concentration of eggs in the stool using the formalin-ether concentration technique (FECT) and collection of stool samples over several consecutive days have been applied (Utzinger et al. 2001; Booth et al. 2003; Ridley and Hawgood 1956). However, these modifications are too laborious in large-scale nationwide surveys (Weerakoon et al. 2015). Although point-of-care diagnostic test (POCT) kits are available for other schistosome species, sensitivities of these kits in the diagnosis of S. japonicum infection were unsatisfactory (van Dam et al. 2015). Moreover, the diagnostic performance of POC-CCA which is a POCT to detect S. mansoni infection correlates with the intensity of infection and its sensitivity may decrease in cases with a low parasite burden, similar to stool microscopy (Stothard et al. 2006; Tchuem Tchuenté et al. 2012; Legesse and Erko 2007). An ELISA with the recombinant antigen that can detect early infection with high sensitivity and specificity may provide an alternative mean which can be a reliable replacement of stool microscopy and POCT for detecting S. japonicum infection in large-scale nationwide surveys.
Cathepsin B (CatB) is a lysosomal cysteine protease found in the gut of schistosome parasite. The parasite uses CatB as a major enzyme for nutrient acquisition through hemoglobin metabolism (Caffrey et al. 2004). CatB is identified in the acetabular gland as the main enzyme in the cercarial stage of S. japonicum. The parasite uses the enzyme to dissolve collagen IV, fibronectin, and laminin in the extracellular matrix of the host skin during penetration (Dvorak et al. 2008; Curwen and Wilson 2003). The abundant expression of the enzyme in the cercarial stage of S. mansoni particularly in the cecum and protonephridia is also reported (El Ridi et al. 2014; Skelly and Shoemaker 2001). The crucial role of this enzyme in the parasite makes it an ideal target for drug and vaccine development (Smooker et al. 2010; Wasilewski et al. 1996). The early exposure of CatB to the host’s immune system also implies an early immune response against this enzyme. Hence, this antigen may have an advantage as a potential marker for the early antibody-based diagnosis of the infection.
In the present study, an ELISA using rSjCatB showed high sensitivity and specificity in detecting the parasite infections both in experimentally infected mice and in stool-confirmed patients. The ELISA data also suggested a potential application of this antigen in the early diagnosis of the infection. Compared with SjTPx-1 which detected only 1 of 3 experimentally infected mice at 6 weeks post-infection (Fig. S1), rSjCatB detected 2 of 3 experimentally infected mice at 6 weeks post-infection. Here, we observed a varying antibody response with rSjCatB that can be attributed to the fact that there is a possibility of different infectivity levels of these mice post cercarial challenge (Maloney and Webbe 1982). Furthermore, antibodies against rSjCatB were detected at 6 weeks post-infection before the parasite fully develops into an adult and starts to lay eggs. This finding validates the data from previous studies with S. mekongi CatB (Sangfuang et al. 2016) and S. mansoni CatB (Ruppel et al. 1985a, b), in which specific antibodies were detected from as early as 4 weeks post-infection. Early detection is beneficial in cases of acute infection, such as in tourist potentially exposed to the disease where eggs of the parasite are not detected in the stool beyond 8 weeks post-infection. Earlier diagnosis could provide travelers suspected of exposure with early access to treatment and thus prevent the introduction of the disease into an uncontaminated environment as well as the pathological damage induced by egg deposition in vital organs. The results of the present study showed that SjCatB has high sensitivity and specificity in the diagnosis of S. japonicum infection, even in the early stages of infection, with minimal cross-reactivity with other parasitic infections.
The environmental changes brought about by the development of water resources, such as the building of dams, which introduces the intermediate snail hosts, as well as the migration of patients and reservoir animals into other previously non-endemic areas, may give rise to new endemic foci (Patz et al. 2000; Ross et al. 2001). Effective screening of individuals and animals moving from schistosomiasis-endemic areas may prevent the introduction of the disease in non-endemic areas. Thus, a sensitive and specific test that can detect early-stage schistosomiasis infection may have an advantage over the traditional diagnostic methods that are currently applied and may in turn improve elimination programs that are currently set in place.
Taken together, SjCatB, which showed high sensitivity and specificity in the detection of S. japonicum infection may be a promising serodiagnostic antigen. To facilitate its field application, additional experiments with larger numbers of samples from humans and animals are currently underway.
References
Angeles JMM, Goto Y, Kirinoki M, Asada M, Leonardo LR, Rivera PT, Villacorte EA, Inoue N, Chigusa Y, Kawazu S (2012) Utilization of ELISA using thioredoxin peroxidase-1 and tandem repeat proteins for diagnosis of Schistosoma japonicum infection among water buffaloes. PLOS Negl Trop Dis 6:e1800
Booth M, Vounatsou P, Ngoran EK, Tanner M, Utzinger J (2003) The influence of sampling effort and the performance of the Kato-Katz technique in diagnosing Schistosoma mansoni and hookworm co-infections in rural Côte d'Ivoire. Parasitology 127:525–531
Caffrey CR, McKerrow JH, Salter JP, Sajid M (2004) Blood ‘n’guts: an update on schistosome digestive peptidases. Trends Parasitol 20:241–248
Centers for Disease Control website https://www.cdc.gov/parasites/schistosomiasis/health_professionals/index.html Accessed 25 August, 2017
Chitsulo L, Engels D, Montresor A, Savioli L (2000) The global status of schistosomiasis and its control. Acta Trop 77:41–51
Curwen RS, Wilson RA (2003) Invasion of skin by schistosome cercariae: some neglected facts. Trends Parasitol 19(2):63–66 discussion 66-8
Dvorak J, Mashiyama ST, Braschi S, Sajid M, Knudsen GM, Hansell E, Lim KC, Hsieh I, Bahgat M, Mackenzie B, Medzihradszky KF, Babbitt PC, Caffrey CR, McKerrow JH (2008) Differential use of protease families for invasion by schistosome cercariae. Biochimie 90(2):345–358
El Ridi R, Tallima H, Dalton JP, Donnelly S (2014) Induction of protective immune responses against schistosomiasis using functionally active cysteine peptidases. Front Genet 5:119
González AY, Sulbarán GS, Ballen DE, Cesari IM (2015) Immunocapture of circulating Schistosoma mansoni cathepsin B antigen (Sm31) by anti-Sm31 polyclonal antibodies. Parasitol Int 65(3):191–195
Karcher H, Loddenkemper C, Zeitz M, Schneider T (2008) Intestinal schistosomiasis in a traveler returning from Rwanda and Burundi. Int J Color Dis 23:1021–1022
Katz N, Chaves A, Pellegrino J (1972) A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 14:397–400
Legesse M, Erko B (2007) Field-based evaluation of a reagent strip test for diagnosis of Schistosoma mansoni by detecting circulating cathodic antigen in urine before and after chemotherapy. Trans R Soc Trop Med Hyg 101:668–673
Leonardo L, Rivera P, Saniel O, Antonio Solon J, Chigusa Y, Villacorte E, Christopher Chua J, Moendeg K, Manalo D, Chrisostomo B, Sunico L, Boldero N, Payne L, Hernandez L, Velayudhan R (2015) New endemic foci of schistosomiasis infections in the Philippines. Acta Trop 141:354–360
Liu S, Cai P, Piao X, Hou N, Zhou X, Wu C, Wang H, Chen Q (2014) Expression profile of the Schistosoma japonicum degradome reveals differential protease expression patterns and potential anti-schistosomal intervention targets. PLoS Comput Biol 10(10):e1003856
Mahmoud AAF (2001) Schistosomiasis. Tropical Medicine Science and Practice, vol 3. Singapore, Imperial College Press
Maloney NA, Webbe G (1982) A rapid method for the infection of laboratory mice with Schistosoma japonicum. Trans R Soc Trop Med Hyg 76(2):200–203
Patz JA, Graczyk TK, Geller N, Vittor AY (2000) Effects of environmental change on emerging parasitic diseases. Int J Parasitol 30:1395–1405
Pontes LA, Oliveira MC, Katz N, Dias-Neto E, Rabello A (2003) Comparison of a polymerase chain reaction and the Kato-Katz technique for diagnosing infection with Schistosoma mansoni. Am J Trop Med Hyg 68:652–656
Ridley DS, Hawgood BC (1956) The value of formol-ether concentration of faecal cysts and ova. J Clin Pathol 9:74–76
Ross AG, Sleigh AC, Li Y, Davis GM, Williams GM, Jiang Z, Feng Z, McManus DP (2001) Schistosomiasis in the People’s Republic of China: prospects and challenges for the 21st century. Clin Microbiol Rev 14:270–295
Ruppel A, Diesfeld HJ, Rother U (1985a) Immunoblot analysis of Schistosoma mansoni antigens with sera of schistosomiasis patients: diagnostic potential of an adult schistosome polypeptide. Clin Exp Immunol 62:499–506
Ruppel A, Rother U, Vongerichten H, Lucius R, Diesfeld HJ (1985b) Schistosoma mansoni: immunoblot analysis of adult worm proteins. Exp Parasitol 60:195–206
Ruppel A, Shi YE, Wei DX, Diesfeld HJ (1987) Sera of Schistosoma japonicum-infected patients cross-react with diagnostic 31/32 kD proteins of S. mansoni. Clin Exp Immunol 69:291–298
Sangfuang M, Chusongsang Y, Limpanont Y, Vanichviriyakit R, Chotwiwatthanakun C, Sobhon P, Preyavichyapugdee N (2016) Schistosoma mekongi cathepsin B and its use in the development of an immunodiagnosis. Acta Trop 155:11–19
Skelly PJ, Shoemaker CB (2001) Schistosoma mansoni proteases Sm31 (cathepsin B) and Sm32 (legumain) are expressed in the cecum and protonephridia of cercariae. J Parasitol 87:1218–1221
Smooker PM, Jayaraj R, Pike RN, Spithill TW (2010) Cathepsin B proteases of flukes: the key to facilitating parasite control? Trends Parasitol 26:506–514
Stothard JR, Kabatereine NB, Tukahebwa EM, Kazibwe F, Rollinson D, Mathieson W, Webster JP, Fenwick A (2006) Use of circulating cathodic antigen (CCA) dipsticks for detection of intestinal and urinary schistosomiasis. Acta Trop 97:219–228
Tchuem Tchuenté LA, Kueté Fouodo CJ, Kamwa Ngassam RI, Sumo L, Dongmo Noumedem C, Kenfack CM, Gipwe NF, Nana ED, Stothard JR, Rollinson D (2012) Evaluation of circulating cathodic antigen (CCA) urine-tests for diagnosis of Schistosoma mansoni infection in Cameroon. PLoS Negl Trop Dis 6:e1758
Utzinger J, Booth M, N’Goran EK, Muller I, Tanner M, Lengeler C (2001) Relative contribution of day-to-day and intra-specimen variation in faecal egg counts of Schistosoma mansoni before and after treatment with praziquantel. Parasitol 122:537–544
van Dam GJ, Odermatt P, Acosta L, Bergquist R, de Dood CJ, Kornelis D, Muth S, Utzinger J, Corstjens PL (2015) Evaluation of banked urine samples for the detection of circulating anodic and cathodic antigens in Schistosoma mekongi and S. japonicum infections: a proof-of-concept study. Acta Trop 141:198–203
Wasilewski MM, Lim KC, Phillips J, McKerrow JH (1996) Cysteine protease inhibitors block schistosome hemoglobin degradation in vitro and decrease worm burden and egg production in vivo. Mol Biochem Parasitol 81:179–189
Weerakoon KG, Gobert GN, Cai P, McManus DP (2015) Advances in the diagnosis of human schistosomiasis. Clin Microbiol Rev 28:939–967
Yu JM, de Vlas SJ, Jiang QW, Gryseels B (2007) Comparison of the Kato-Katz technique, hatching test and indirect hemagglutination assay (IHA) for the diagnosis of Schistosoma japonicum infection in China. Parasitol Int 56:45–49
Zhang Y, Zhao J, Wang X, Xu X, Pan W (2015) Evaluation of six novel antigens as potential biomarkers for the early immunodiagnosis of schistosomiasis. Parasit Vectors 8:447. https://doi.org/10.1186/s13071-015-1048-2
Zhou XH, Wu JY, Huang XQ, Kunnon SP, Zhu XQ, Chen XG (2010) Identification and characterization of Schistosoma japonicum Sjp40, a potential antigen candidate for the early diagnosis of schistosomiasis. Diagn Microbiol Infect Dis 67:337–345
Zhu YC (2005) Immunodiagnosis and its role in schistosomiasis control in China: a review. Acta Trop 96:130–136
Acknowledgments
We thank Dr. Hiroshi Ohmae of the National Institute of Infectious Diseases, Japan, for providing the schistosomiasis-positive serum samples; Dr. Isao Nagano of the Department of Parasitology, Gifu University Graduate School of Medicine for the O. viverrini-positive samples; Dr. Haruhiko Maruyama of Miyazaki University Graduate School of Medicine for the P. westermani-positive samples.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving animals were in accordance with the ethical standards of Obihiro University of Agriculture and Veterinary Medicine, Japan, animal committee (approval no. 29-52).
Additional information
Section Editor: Xing-Quan Zhu
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(PPTX 45 kb)
Rights and permissions
About this article
Cite this article
Macalanda, A.M.C., Angeles, J.M.M., Moendeg, K.J. et al. Schistosoma japonicum cathepsin B as potential diagnostic antigen for Asian zoonotic schistosomiasis. Parasitol Res 118, 2601–2608 (2019). https://doi.org/10.1007/s00436-019-06410-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-019-06410-x